These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2515215)

  • 1. Sustained high-dose nitroglycerin transcutaneous patch therapy in angina pectoris: evidence for attenuation of effect over time.
    Frishman WH; Giles T; Greenberg S; Heiman M; Raffidal L; Soberman J; Laifer L; Nadelmann J; Lazar E; Strom J
    J Clin Pharmacol; 1989 Dec; 29(12):1097-105. PubMed ID: 2515215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Steering Committee, Transdermal Nitroglycerin Cooperative Study.
    Am J Cardiol; 1991 Nov; 68(13):1263-73. PubMed ID: 1951111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
    Parker JD; Parker AB; Farrell B; Parker JO
    Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.
    Greco R; D'Alterio D; Schiattarella M; Boccia A; Greco L; Marsico F
    Am J Cardiol; 1988 Mar; 61(9):44E-51E. PubMed ID: 3126635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of transdermal nitroglycerin to improve exercise capacity in patients with angina pectoris.
    Sullivan M; Savvides M; Abouantoun S; Madsen EB; Froelicher V
    J Am Coll Cardiol; 1985 May; 5(5):1220-3. PubMed ID: 3921585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal nitroglycerin in angina pectoris.
    Parker JO; Fung HL
    Am J Cardiol; 1984 Sep; 54(6):471-6. PubMed ID: 6433687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the day-long antianginal effectiveness of nitroglycerin patches with that of three-times-daily isosorbide dinitrate: a double-blind study using dose titration.
    Bassan MM; Rogel S
    Eur Heart J; 1992 Sep; 13(9):1265-70. PubMed ID: 1396839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic efficacy of low-dose nitroglycerin patches in stable angina pectoris.
    Rezaković DE; Lakatos S; Stalec J; Pavicić L
    Z Kardiol; 1986; 75 Suppl 3():90-5. PubMed ID: 3099489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The day-long antianginal effectiveness of nitroglycerin patches. A double-blind study using dose-titration.
    Bassan M
    Chest; 1991 May; 99(5):1120-5. PubMed ID: 1902159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval.
    Schaer DH; Buff LA; Katz RJ
    Am J Cardiol; 1988 Jan; 61(1):46-50. PubMed ID: 3122549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects on exercise tolerance of a new transdermal therapeutic system containing nitroglycerine, in patients with stable angina pectoris.
    Carù B; Pirelli S; Ferratini M; Gasparini M; Cattafi G; Corrada E; Pollavini P
    Eur Heart J; 1988 Jan; 9 Suppl A():105-11. PubMed ID: 3137062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.
    DeMots H; Glasser SP
    J Am Coll Cardiol; 1989 Mar; 13(4):786-95. PubMed ID: 2494240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris.
    Rezaković DE; Pavicić L; Majacić M
    Eur Heart J; 1988 Jan; 9 Suppl A():73-81. PubMed ID: 3137073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic efficacy of 10 mg of nitroglycerin patch in stable angina pectoris.
    Rezaković DE; Stalec J
    Am J Cardiol; 1988 Mar; 61(9):52E-58E. PubMed ID: 3126636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina.
    Parker JD; Parker AB; Farrell B; Parker JO
    Circulation; 1996 Feb; 93(4):691-6. PubMed ID: 8640997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical benefit of transdermal glyceryl trinitrate when used with an eight hour patch-free period.
    Whalley DW; Hellestrand KJ
    Aust N Z J Med; 1990 Oct; 20(5):677-81. PubMed ID: 2126727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained effects of transdermal nitroglycerin in patients with angina pectoris.
    Kapoor AS; Dang NS; Reynolds RD
    Clin Ther; 1985; 7(6):674-9. PubMed ID: 3935313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group.
    Parker JO; Amies MH; Hawkinson RW; Heilman JM; Hougham AJ; Vollmer MC; Wilson RR
    Circulation; 1995 Mar; 91(5):1368-74. PubMed ID: 7867175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic effects of transdermal nitroglycerin in stable angina pectoris: a within-patient, placebo-controlled study.
    Gibelli G; Negrini M; Bruno AM; Fiorini GL; Lambiase M; Magenta G; Corti D; Prina L; Pollavini PG; De Ponti C
    Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):436-41. PubMed ID: 2509380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort angina pectoris: a multicentric study. The Collaborative Nitro Group.
    Scardi S; Camerini F; Pandullo C; Pollavini G
    Int J Cardiol; 1991 Aug; 32(2):241-8. PubMed ID: 1917174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.